• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • Contact

News

News · November 13, 2020

Dentsply Sirona and Panthera Dental announce collaboration: fully digital workflow for custom-made sleep devices

panthera

(Charlotte/Quebec, November 12, 2020) Dentists now have the opportunity to use Primescan in a new area of application: Obstructive Sleep Apnea (OSA) and snoring, which affects up to 3.61 billion …

News · October 27, 2020

TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history

lifescience

The Fund continues the proven “Project Focused Company” investment strategy for early-stage drug development candidates. In addition, the Fund continues to invest in late-stage clinical …

News · October 22, 2020

CENTOGENE Announces Leadership Transition

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world …

Event Preview, Events, News · September 8, 2020

2022 TVM Capital Winter Conference

grand hotel kitzbuehl

Dear Friends and Partners of TVM Capital Life Science. In light of the ongoing (COVID-19) coronavirus outbreak and the resulting travel restrictions, we have decided to postpone the TVM Winter …

News · July 15, 2020

CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …

News · July 10, 2020

CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares

centogene

July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 47
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

Kent’s deal with Net Health to expand Snapshot’s footprint

February 25, 2021

TVM Life Science Innovation II SCSp Announces Investment in Vespina Lifesciences Inc.

February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Sarkana Pharma, Inc.

February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in ImmunoRx Pharma, Inc.

January 19, 2021

Kent Imaging Inc. is accelerating its growth through a US$15M investment by TVM Life Science Innovation II SCSp

January 14, 2021

  • in

Copyright © 2021 · TVM Capital Life Science Venture Capital · Privacy Policy · Contact